A
$ Value
$0
Shares
19,683
Price
$0
Filed
Apr 9
Insider
Name
Fowler Christopher L
Title
President and CEO
CIK
0001454872
Roles
Director
Officer
Transaction Details
Transaction Date
2026-04-08
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
136,772
Footnotes
Represents a grant of restricted stock that vests in three annual installments of one-third each beginning on the first anniversary of the grant date. This transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3(d) thereunder.
Filing Info
Fowler Christopher L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-08 | TBRG | A | $0 |
| 2026-03-16 | TBRG | F | $104K |
| 2026-03-13 | TBRG | F | $38K |
| 2026-03-09 | TBRG | F | $39K |
| 2025-07-01 | TBRG | F | $53K |
| 2025-05-16 | TBRG | ▼ | $150K |
| 2024-07-01 | TBRG | F | $16K |
Other Insiders at TBRG (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| DYE DAVID A | — | — | 2026-03-16 |
|
Fowler Christopher L
President and CEO
|
— | — | 2026-03-16 |
|
Plessner Kevin
General Counsel
|
— | — | 2026-04-08 |
|
Bassi Vinay
Chief Financial Officer
|
— | — | 2026-04-08 |
|
MacIntyre Vita
Controller
|
— | — | 2026-04-08 |
|
Harse David
General Manager Patient Care
|
— | — | 2026-04-08 |
|
Wilson Merideth
Financial Health GM
|
— | — | 2026-04-08 |
|
Daughton Michael
Chief Business Officer
|
— | — | 2026-04-08 |